300363 Porton Pharma Solutions
- 20.54
- -0.66-3.11%
Porton Pharma Solutions News
Boteng Co., Ltd.: Investor Relations Activity Record Form for October 25, 2024
Boteng Co., Ltd.: Announcement of Resolutions of the 20th Interim Meeting of the Fifth Board of Supervisors
Boteng shares: 2024 third quarter report
Boteng Co., Ltd.: Announcement on providing guarantees for wholly-owned subsidiaries to apply for comprehensive credit from banks
Boteng Co., Ltd.: Announcement of Resolutions of the 28th Interim Meeting of the Fifth Board of Directors
Boteng Co., Ltd.: Announcement on the completion of industrial and commercial change registration for wholly-owned subsidiaries
Boteng Co., Ltd.: Announcement on the completion of industrial and commercial change registration for wholly-owned subsidiaries
Boteng Co., Ltd.: Announcement on the actual controller\'s partial share pledge and release of the pledge
Boteng Co., Ltd.: Announcement on the completion of the plan to increase the shareholding of senior management
Boteng Co., Ltd.: Attached to the Investor Relations Activity Record Form for August 28, 2024
Boteng Co., Ltd.: Investor Relations Activity Record Form for August 28, 2024
Boteng Co., Ltd.: Announcement on providing guarantees for wholly-owned subsidiaries to apply for comprehensive credit from banks
Boteng Co., Ltd.: General Manager Work Rules (August 2024)
Boteng Co., Ltd.: Announcement on changes in accounting policies
Boteng shares: 2024 semi-annual report
Boteng Co., Ltd.: Public Opinion Management System (August 2024)
Boteng Co., Ltd.: Table of non-operating capital occupation and other related capital transactions for the first half year of 2024
Boteng Shares: 2024 Semi-Annual Report Summary
Boteng Co., Ltd.: Announcement of Board Resolutions
Boteng Shares: CITIC Securities Co., Ltd.\'s inspection opinions on the progress of Chongqing Boteng Pharmaceutical Technology Co., Ltd.\'s plans to adjust some fund-raising investment projects
Analysis
Price Target
No Data
No Data